FIELD: veterinary medicine.
SUBSTANCE: invention relates to the field of veterinary medicine, in particular to the treatment of infectious diseases of cats. A pharmaceutical composition for antiviral therapy of feline infectious peritonitis (FIP) has been proposed, which includes (2R,3R,4S,5R)-2-(4-aminopyrrolo[2,1-f][1,2,4]triazine-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-carbonitrile and taurine as active ingredients.
EFFECT: invention expands the arsenal of antiviral agents for the treatment of feline infectious peritonitis.
9 cl, 3 tbl, 15 ex
Authors
Dates
2022-09-19—Published
2021-12-24—Filed